Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
| Fiscal year | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Cash | $1664 | $2602 | $33.5K2 | |
| Current assets | $1664 | $17.1K2 | $33.5K2 | |
| Total assets | $1664 | $17.1K2 | $33.5K2 | |
| Current liabilities | $98.7K4 | $1.8M2 | $466.5K2 | |
| Total liabilities | $138.7K4 | $1.8M2 | $466.5K2 | |
| Retained earnings | -$10.7M2 | |||
| Shareholders’ equity | -$8.8K4 | -$138.6K2 | -$1.8M2 | -$433.0K2 |
| Shares outstanding | 237.2K shares2 | 8.0M shares4 | 8.8M shares4 | 11.5M shares2 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
What it owns
What Bioquest Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Investments
Former names
Timeline
- May 19, 20228-K Change of auditor8
Filings
21 filings to the SEC since October 2021: 1 annual reports, 4 quarterly reports, 1 major events, 15 other. The latest 20:
- Oct 8, 2024253G2 EDGAR
- Aug 28, 20241-U EDGAR
- Aug 21, 2024QUALIF EDGAR
- Aug 19, 2024CORRESP EDGAR
- Jul 30, 2024CORRESP EDGAR
- Jul 26, 20241-A/A EDGAR
- Jul 15, 2024UPLOAD EDGAR
- Jul 1, 2024CORRESP EDGAR
- Jul 1, 20241-A/A EDGAR
- Jun 11, 2024UPLOAD EDGAR
- May 15, 20241-A EDGAR
- Apr 17, 20241-Z EDGAR
- Jan 27, 202315-12G EDGAR
- Dec 7, 2022NT 10-Q EDGAR
- Sep 12, 202210-Q EDGAR
- Aug 15, 202210-K EDGAR
- Jul 26, 2022NT 10-K EDGAR
- May 27, 202210-Q EDGAR
- May 19, 20228-K EDGAR
- May 16, 202210-Q EDGAR
The 21 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How Bioquest Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARBioquest Corp1
- CIK0001568628
- Employer ID (EIN)99-03788541
- Filer statusNon-accelerated filer<br>smaller reporting company1
- Incorporated inNevada1
- Fiscal year endsApril 301
- Industry code (SIC)2834 Pharmaceutical Preparations1
- SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
- Business address4570 Campus Drive #23, Newport Beach, Newport Beach, CA 926601
- Phone418-264-71341
- Shares outstanding11,485,320,230 as of Jul 31, 20227
- Public float$585.5K as of Apr 30, 20222
- On EDGAR sinceFeb 5, 20131
- Filings81 in all: 10-Q (12), 8-K (9), CORRESP (9), UPLOAD (8), 1-A/A (6), NT 10-Q (4), 1-A (3), 10-K (3)1
All 24 form types
8-K/A (3), NT 10-K (3), QUALIF (3), S-1/A (3), 1-Z (2), 253G2 (2), 424B3 (2), 1-A-W (1), 1-U (1), 10-K/A (1), 15-12G (1), 15-15D (1), 8-A12G (1), EFFECT (1), S-1 (1), S-8 (1)
- Latest filingsAnnual report (10-K) Aug 15, 2022
Quarterly report (10-Q) Sep 12, 2022
Latest 8-K (8-K) May 19, 2022
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARBioquest Corp filings on SEC EDGAR
- 2SEC EDGARBioquest Corp 10-K for fiscal 2022
- 3SEC EDGARBioquest Corp filings on SEC EDGAR
- 4SEC EDGARBioquest Corp 10-K for fiscal 2020
- 5SEC EDGARBioquest Corp 10-Q for fiscal 2021
- 6SEC EDGARBioquest Corp 10-Q for fiscal 2022
- 7SEC EDGARBioquest Corp 10-Q for fiscal 2022
- 8SEC EDGARChange of auditor